Is a Quality-Assurance Step a Liability? What Capital Work Taught Me About Defensibility

Capital cases read a report the way no other case does.

The Atkins claim. The competency-to-be-executed evaluation. The mitigation workup. These are the reports most likely to be deposed, litigated, and re-litigated — sometimes years after we signed them. In a death-penalty posture, a report is not read once and filed. It is read line by line, by opposing counsel, by a mitigation specialist, and often by a second expert retained for the sole purpose of finding the seam in our methodology.

If you do this work, none of that is news. It is the pressure you already carry every time you finalize an opinion in a capital matter.

What has changed is how little room the courtroom now leaves for a report that isn't airtight.

The scrutiny is structural, not personal

The standards themselves invite challenge. In intellectual-disability determinations, the Supreme Court has steadily pushed evaluations toward prevailing clinical standards — rejecting a rigid IQ cutoff in Hall v. Florida (2014) and rejecting the offsetting of deficits against unconnected strengths in Moore v. Texas (2017). In competency-to-be-executed work, Ford v. Wainwright (1986) and later Panetti v. Quarterman (2007) framed the inquiry around a defendant's rational understanding — a standard that turns heavily on how carefully the evaluator reasons and documents.

Each of those holdings is, in effect, an instruction to opposing counsel: here is where a methodology can be attacked.

Then there is the evidentiary gate. The December 2023 amendment to Federal Rule of Evidence 702 clarified that the proponent of expert testimony must establish admissibility by a preponderance of the evidence, and that the expert's opinion must reflect a reliable application of methods to the facts of the case. The Advisory Committee was explicit that the change was meant to correct years of courts treating expert testimony as presumptively admissible and waving concerns off to cross-examination. The practical effect, as the defense and plaintiff bars alike have noted, is that "we can explore that on cross" is a weaker answer than it used to be. More of the reliability question is being resolved before anyone reaches the stand.

For those of us writing the reports, that raises the cost of a defensible weakness we didn't catch ourselves.

The objection I hear most

When I describe a quality-assurance layer — a structured review of a completed report before it's finalized — the first reaction from experienced evaluators is often a version of this:

"Doesn't running my report through something extra suggest I wasn't sure? Couldn't that itself become a problem on cross?"

It is a fair instinct, and it deserves a real answer rather than a reassuring one.

Start with what the concern gets right and what it gets wrong.

Consultation has never been an admission of doubt

Consider how we already work. We consult colleagues on hard cases. We re-read the governing standard. We check a scoring table twice. We ask a trusted peer to pressure-test a conclusion before we commit to it in writing.

None of that is treated as doubt. It is diligence — and our own field frames it that way. The APA Specialty Guidelines for Forensic Psychology (2013) list the opportunity for consultation among the factors bearing on competence, and note that even on subjects in which they are expert, forensic practitioners may choose to consult with colleagues. Consultation is, in the profession's own language, a route to competence, not evidence against it.

A structured quality-assurance review sits in that same tradition. It does not generate an opinion. It does not touch clinical judgment. It asks one question about a report we have already written: if this were challenged tomorrow, where is it vulnerable — in its methodology, in its language, and on cross-examination?

Finding that seam before opposing counsel does is not a liability. In a capital case, it is close to the entire job.

The honest caveat: the disclosure question is genuinely open

Here is where I want to be careful, because this is a new kind of tool and the norms around it are not settled.

Whether the use of a quality-assurance step is discoverable, and whether it should be disclosed, is a legal question — not a clinical one, and not one a vendor should answer for you. It may vary by jurisdiction, by the posture of the case, and by how your retaining counsel manages work product. I am not going to tell you it is never discoverable, or that it never needs to be mentioned, because I don't think anyone can responsibly say that yet.

What I will say is that this is a question to raise proactively with the attorney who retained you, the same way you would think through any part of your file that could surface in discovery. The right posture is to know your answer before you're asked it, not to assume the answer.

That caution is the point, not a footnote to it. A tool that makes your reasoning more defensible is only an asset if you use it with the same care you bring to everything else in a capital file.

Three questions to ask before you upload anything

If you are weighing any review layer, mine or otherwise, the buying criteria matter more than the marketing. Before a completed report leaves your control, ask:

Does the tool support my judgment, or does it try to substitute for it? Anything that drafts, scores, or nudges a clinical opinion is a different and more dangerous category than a tool that reviews a finished report for defensibility.

How does it handle protected health information, and can I document that handling? In a capital file, the answer needs to be one you could defend in the same room where the report will be defended.

Can I explain, plainly, what the tool did and did not do? If you can't describe it in a sentence to a judge, you are not ready to rely on it.

A quality-assurance review, used well, doesn't make you look less certain. It's how careful evaluators get to stay certain because the vulnerable seam got found on our side of the table first.

For those of you doing capital work: how do you currently pressure-test a report before it leaves your desk?

References

American Psychological Association. (2013). Specialty guidelines for forensic psychology. American Psychologist, 68(1), 7–19. https://doi.org/10.1037/a0029889

Atkins v. Virginia, 536 U.S. 304 (2002).

Fed. R. Evid. 702 (amended Dec. 1, 2023).

Ford v. Wainwright, 477 U.S. 399 (1986).

Hall v. Florida, 572 U.S. 701 (2014).

Moore v. Texas, 581 U.S. 1 (2017).

Panetti v. Quarterman, 551 U.S. 930 (2007).